Company & Sponsor Intelligence

Universita di Verona

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials4

Recruiting1

Completed1

Countries1

Therapeutic footprint

alzheimersparkinsonsstroke

Indexed studies

NCT07761936Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fluctuations
parkinsons · ItalyPHASE3

NCT04323501Post-stroke Recovery (PSR_e2020)
stroke · ItalyNA

NCT04413240Telerehabilitation for Post-stroke Patients
stroke · ItalyNA

NCT02462291New Approach for Treatment of Behavioral Disorders in Alzheimer's Disease (Alzheimer's Behavioral and Cognitive Disorders)
alzheimers · ItalyNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →